Literature DB >> 33571256

Knowledge, attitudes, and practices of seasonal influenza vaccination in postpartum women, Honduras.

Zachary J Madewell1, Rafael Chacón-Fuentes1, Jorge Jara1, Homer Mejía-Santos2, Ida-Berenice Molina3, Juan Pablo Alvis-Estrada1, Rosa Coello-Licona4, Belinda Montejo4.   

Abstract

BACKGROUND: Influenza during pregnancy may cause serious neonatal outcomes including stillbirth, fetal distress, preterm birth, congenital abnormalities, and stunted growth. Pregnant women are the highest priority group for seasonal influenza vaccination, but low coverage has been repeatedly reported in this population. Understanding reasons for and for not receiving the seasonal influenza vaccine is needed to design communication strategies to increase vaccination coverage. This study aimed to describe knowledge, attitudes, and practices (KAP) of seasonal influenza vaccination among women giving birth in public maternity hospitals in Honduras.
METHODS: From August 20-October 8, 2018, we conducted a cross-sectional KAP survey regarding seasonal influenza vaccinations to a sample of postpartum women who gave birth in maternity hospitals and clinics from the Ministry of Health of Honduras and Honduran Social Security Institute. We reported frequency distributions for demographics, KAP of influenza vaccine, and vaccination coverage. We used logistic regression to analyze unadjusted and adjusted associations between sociodemographic characteristics and influenza vaccination.
RESULTS: We surveyed 842 postpartum women in 17 healthcare facilities. Of 534 postpartum women with term pregnancy and verified vaccinations, 417 (78.1%; 95% CI: 74.6-81.6%) were vaccinated for influenza. Factors associated with verified influenza vaccination included receipt of vaccination recommendations by a healthcare worker during prenatal check-ups (aOR: 16.46; 95% CI: 9.73-27.85), concurrent chronic disease (aOR: 5.00; 95% CI: 1.25-20.07), and influenza vaccination of other children in the household (aOR: 2.28; 95% CI: 1.19-4.39). The most cited reasons for vaccination were perceived benefits for both mother and infant and easy access. Reasons for non-vaccination were: vaccine was not offered and fear of side effects, harm to the infant, and needles or pain caused by injection.
CONCLUSION: Influenza vaccination was well received among postpartum women in Honduras. Increasing clinician recommendations for vaccination and assuring the vaccine is readily available to women during prenatal visits may increase vaccination rates.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33571256      PMCID: PMC7877664          DOI: 10.1371/journal.pone.0246385

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  31 in total

1.  Vaccines against influenza WHO position paper – November 2012.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2012-11-23

2.  Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany.

Authors:  Birte Bödeker; Dietmar Walter; Sabine Reiter; Ole Wichmann
Journal:  Vaccine       Date:  2014-06-10       Impact factor: 3.641

3.  The burden of influenza illness in children with asthma and other chronic medical conditions.

Authors:  K M Neuzil; P F Wright; E F Mitchel; M R Griffin
Journal:  J Pediatr       Date:  2000-12       Impact factor: 4.406

4.  Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: results from a national survey.

Authors:  Béatrice Blondel; Nada Mahjoub; Nicolas Drewniak; Odile Launay; François Goffinet
Journal:  Vaccine       Date:  2012-07-07       Impact factor: 3.641

Review 5.  Influenza virus infection in pregnancy: a review.

Authors:  Wouter J Meijer; Aleid G A van Noortwijk; Hein W Bruinse; Annemarie M J Wensing
Journal:  Acta Obstet Gynecol Scand       Date:  2015-06-13       Impact factor: 3.636

6.  Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.

Authors:  Birte Bödeker; Cornelius Remschmidt; Patrick Schmich; Ole Wichmann
Journal:  BMC Public Health       Date:  2015-07-07       Impact factor: 3.295

7.  Determination of Predominance of Influenza Virus Strains in the Americas.

Authors:  Eduardo Azziz-Baumgartner; Rebecca J Garten; Rakhee Palekar; Mauricio Cerpa; Sara Mirza; Alba Maria Ropero; Francisco S Palomeque; Ann Moen; Joseph Bresee; Michael Shaw; Marc-Alain Widdowson
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

8.  Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Respir Med       Date:  2018-12-12       Impact factor: 30.700

Review 9.  Maternal influenza and birth outcomes: systematic review of comparative studies.

Authors:  D B Fell; D A Savitz; M S Kramer; B D Gessner; M A Katz; M Knight; J M Luteijn; H Marshall; N Bhat; M G Gravett; B Skidmore; J R Ortiz
Journal:  BJOG       Date:  2016-06-06       Impact factor: 6.531

10.  Determinants of pregnant women's knowledge about influenza and the influenza vaccine: A large, single-centre cohort study.

Authors:  Stéphanie Bartolo; Ophélie Mancel; Emilie Deliege; Sophie Carpentier; Rodrigue Dessein; Karine Faure; Damien Subtil
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

View more
  2 in total

1.  Association between risk perception and influenza vaccine hesitancy for children among reproductive women in China during the COVID-19 pandemic: a national online survey.

Authors:  Min Du; Liyuan Tao; Jue Liu
Journal:  BMC Public Health       Date:  2022-02-23       Impact factor: 3.295

2.  Knowledge, attitudes, and practices for the use of seasonal influenza vaccination, healthcare workers, Costa Rica.

Authors:  Zachary Madewell; Rafael Chacón-Fuentes; Xiomara Badilla-Vargas; Catalina Ramirez; Maria-Renee Ortiz; Juan-Pablo Alvis-Estrada; Jorge Jara
Journal:  J Infect Dev Ctries       Date:  2021-07-31       Impact factor: 2.552

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.